InfoComm 2019: Retailtainment is the New Reality for Malls. What Does This Mean for AV?

 

Like many industries, retail is facing the full effect of the experience economy. Couple this with the standardized convenience of e-commerce, and it becomes clear the future of brick and mortar stores is at a critical point. Nowhere is this need for an experience beyond the product in retail more evident than at our malls.

In this InfoComm 2019 episode of the Pro AV Podcast, host Daniel Litwin discussed this new blend of retail and entertainment and how it’s affecting the Pro AV industry with Jackie Wolford, director of Design Studio for AOA and Louis Alfieri, principal and chief creative officer for Raven Sun Creative.

Litwin met up with Wolford and Alfieri after their seminar at InfoComm: “Retailtainment: Attractions are Bringing Customers to the Mall.” The two thought leaders discussed how interactivity, personalization, and entertainment are key trends in retail, and all are being facilitated by the latest Pro AV technologies.

These sophisticated new experiences are creating a new kind of mall as the lines between retail and entertainment blur to create the unique out-of-home experience that is retailtainment. For example, content creators like Wolford are layering projection mapping with live entertainment.

“You can take the story and create moments that the guest can connect to,” said Wolford, who has created experiences with well-known brands such as Disney, Universal, Caribbean Cruise Lines, SeaWorld, Sands, and Virgin. “Tech is a great tool for doing that and creating that connection with your guests.”

Alfieri is seeing the manifestation of retail stores, such as Nike, use content and storytelling to create truly unique experiences that make customers feel part of an experience.

“Retailers are creating a neighborhood feel for consumers,” he said.

Listen to Wolford and Alfieri recap their educational session at InfoComm, why storytelling is driving the best retail content, how retailtainment is putting more of a creative emphasis on AV professionals.

For the latest news, videos, and podcasts in the Pro AV Industry, be sure to subscribe to our industry publication. A new episode of the Pro AV Show drops every Thursday.

Follow us on social media for the latest updates in B2B!

Twitter – @ProAVMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More